At a glance
ClinicalIndex Comparison RecordN/ACompleted· 671 enrolled
Drug / intervention
LAP-BAND AP® Adjustable Gastric Banding Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
HERO Study: Helping Evaluate Reduction in Obesity
In Brief
An observational study evaluating LAP-BAND AP® Adjustable Gastric Banding System for Obesity. Completed, enrolled 671 participants across 6 sites in 6 countries.
Detailed Summary
A prospective, international, multi-center study of clinical outcomes and estimated healthcare resource expenditures associated with the treatment of obesity using the LAP-BAND AP® Adjustable Gastric Banding System.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesAustralia, Belgium, Canada, Italy, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 2009
Enrollment StartDec 2009
Primary CompletionJul 2016
Study CompletionOct 2016
TodayJul 2026
First PostedAug 6, 2009
Enrollment StartDec 1, 2009
Primary CompletionJul 1, 2016
Study CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 6.6 yearsPosted 16.9 years ago
Interventions
LAP-BAND AP® Adjustable Gastric Banding Systemdevice
The LAP-BAND AP® is a device surgically implanted via a laparoscopic procedure. It is designed to induce weight loss in severely obese patients by limiting food consumption.